Media & Announcements
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
Polpharma Group’s R&D supports growth in key therapeutic areas.
Polpharma Group's research and development capabilities support growth across its key therapeutic areas and strengthen its product pipeline.
Group News
June 26, 2026
26th International Scientific Conference on Expert Education Programs.
Polpharma joins the 26th International Scientific Conference on Expert Education Programs (EPE2026), supporting expert-led pharmaceutical education.
Group News
June 1, 2026
Polish RNA Technology Platform
Polpharma opens Poland's only end-to-end RNA medicine development platform in Starogard Gdanski, a PLN 238.7m investment strengthening medicine security.
Science & Innovation
May 20, 2026
Polpharma strengthens it's position in CEE - Biofarm, the leader of the Romanian market, joins the Group.
Polpharma Group has completed the acquisition of the Romanian pharmaceutical company Biofarm. The transaction is a clear step in the execution of the Group’s growth strategy and strengthens its position in Central and Eastern Europe.
Group News
July 27, 2026
.avif)
.avif)
The Leonardo Innovation Program won the Gold Stevie Awards® gold statuette in the 19th edition of the prestigious international competition International Business Awards®!
The Leonardo employee innovation programme wins Gold at the Stevie International Business Awards for creativity, engagement and innovative communication.
Group News
August 16, 2022
Polpharma API completed step 1. Risk Evaluation according to EMA’s request concerning presence of nitrosamines in drug products.
Polpharma completed EMA risk assessment for nitrosamines in chemically synthesised APIs, identifying optimisation parameters for highest quality.
Group News
December 17, 2020
Press releases
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Careers
ZF Polpharma
March 30, 2021
POLPHARMA AWARDED IN THE COMPETITION FAMILY AND HUMAN FRIENDLY COMPANY
Polpharma is distinguished in the Humanites Institute's Family and Human Friendly Company competition for supporting staff on maternity and paternity leave.
Careers
ZF Polpharma
March 30, 2021
Polpharma ranked #1 in the Pharmaceuticals and Biotechnology category in the Forbes Poland’s Best Employers 2021 ranking!
Polpharma takes first place in the Pharmaceuticals and Biotechnology category of Forbes Poland's Best Employers 2021, based on an anonymous industry survey.
Corporate Social Responsibility
ZF Polpharma
March 24, 2021
Polpharma has received the 2020 Ethical Company title
Polpharma receives the 2020 Ethical Company title, recognising its ethics and compliance programme plus COVID-19 aid such as ventilators and hospital meals.
Careers
ZF Polpharma
March 4, 2021
Polpharma at the top in the category of the exact sciences in the study „Most Attractive Employer Poland” 2020
Polpharma tops the Natural Sciences category in Universum's Most Attractive Employer Poland 2020 study, voted by over 16,000 students from 71 universities.
Latest stories
featured
.avif)
For the media
Media Kit
Logos, photography and the Group boilerplate.
ZIP file (112.28 kb) updated quarterly
Group factsheet
Revenue, footprint, pipeline, employment and history.
Pdf file (112.28 kb) updated quarterly
Press Contact
Logos, photography and the Group boilerplate.
press@polpharma.com
RESPONDS WITHIN ONE BUSINESS DAY